Home > D. Systemic pathology > Infectious diseases > parvovirus B19

parvovirus B19

Tuesday 13 July 2004

Parvovirus B19 (PVB19) is the causative agent of erythema infectiosum and sometimes the infection is correlated with severe haematological complications, or in pregnancy to fetalis hydrops.

Moreover some authors suggest an infection involvement in some autoimmune diseases. Infection with parvovirus B19 (B19) has been associated with connective tissue disease (CTD) stigmata, namely, a systemic lupus erythematosus (SLE)-like illness, seronegative polyarthritis resembling rheumatoid arthritis, and vasculitis.

Pathology

- parvoviral transient aplastic anemia
- parvoviral pure red cell aplasia
- parvoviral leucopenia
- parvoviral neutropenia
- parvoviral myocarditis
- parvoviral hepatitis
- parvoviral fetopathy

  • nonimmune parvoviral hydrops fetalis (#9670826#)

References

- Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004 Feb 5;350(6):586-97. PMID: #14762186#

Portfolio

  • Parvoviral inclusion in fetal liver (hydrops fetalis)
  • Parvoviral inclusion in fetal liver (hydrops fetalis)
  • Parvoviral inclusion in fetal liver (hydrops fetalis)
  • Parvoviral inclusion in fetal liver (hydrops fetalis)
  • Parvoviral inclusion in fetal liver (hydrops fetalis)
  • Parvovirus B19 cytopathogenic effect in bone marrow
  • Parvovirus B19 cytopathogenic effect in bone marrow
  • Parvovirus B19 cytopathogenic effect in bone marrow
  • Parvovirus B19 cytopathogenic effect in bone marrow
  • Parvovirus B19 cytopathogenic effect in bone marrow
  • Parvovirus B19 cytopathogenic effect in bone marrow